Michelle Skornicki

1.2k total citations · 1 hit paper
24 papers, 857 citations indexed

About

Michelle Skornicki is a scholar working on Endocrinology, Diabetes and Metabolism, Rehabilitation and Occupational Therapy. According to data from OpenAlex, Michelle Skornicki has authored 24 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Rehabilitation and 6 papers in Occupational Therapy. Recurrent topics in Michelle Skornicki's work include Diabetic Foot Ulcer Assessment and Management (8 papers), Wound Healing and Treatments (7 papers) and Pressure Ulcer Prevention and Management (6 papers). Michelle Skornicki is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (8 papers), Wound Healing and Treatments (7 papers) and Pressure Ulcer Prevention and Management (6 papers). Michelle Skornicki collaborates with scholars based in United States, France and United Kingdom. Michelle Skornicki's co-authors include Nathan B. Parsons, Urvi Desai, Alice Kate G. Cummings, Howard G. Birnbaum, J. Bradford Rice, Michael L. Sabolinski, William A. Marston, Robert S. Kirsner, Karen M. Clements and Milton C. Weinstein and has published in prestigious journals such as PLoS ONE, Diabetes Care and Wound Repair and Regeneration.

In The Last Decade

Michelle Skornicki

24 papers receiving 822 citations

Hit Papers

Burden of Diabetic Foot Ulcers for Medicare and Private I... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Burden of Diabetic Foot Ulcers for Medicare and Private Insurers
    2013 437 citations J. Bradford Rice, Urvi Desai et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Skornicki United States 10 501 429 289 231 81 24 857
C. Debure France 14 330 0.7× 133 0.3× 168 0.6× 491 2.1× 160 2.0× 39 883
John S. Steinberg United States 20 681 1.4× 521 1.2× 214 0.7× 764 3.3× 8 0.1× 97 1.3k
Sidnei Lastória Brazil 8 203 0.4× 87 0.2× 153 0.5× 627 2.7× 421 5.2× 26 784
Lauren R. Bayer United States 11 404 0.8× 109 0.3× 92 0.3× 576 2.5× 4 0.0× 13 855
Olle Nelzén Sweden 22 488 1.0× 258 0.6× 384 1.3× 1.7k 7.2× 1.1k 13.9× 41 1.9k
Cornelis G. Vos Netherlands 13 143 0.3× 52 0.1× 39 0.1× 403 1.7× 77 1.0× 34 723
Martin C. Robson United States 10 225 0.4× 74 0.2× 83 0.3× 183 0.8× 13 0.2× 11 444
Satyendra K. Tiwary India 13 103 0.2× 44 0.1× 32 0.1× 408 1.8× 30 0.4× 52 641
Arife Polat Düzgün Türkiye 14 120 0.2× 139 0.3× 71 0.2× 441 1.9× 2 0.0× 33 658
Peter Davison Canada 12 211 0.4× 37 0.1× 29 0.1× 385 1.7× 4 0.0× 27 655

Countries citing papers authored by Michelle Skornicki

Since Specialization
Citations

This map shows the geographic impact of Michelle Skornicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Skornicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Skornicki more than expected).

Fields of papers citing papers by Michelle Skornicki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Skornicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Skornicki. The network helps show where Michelle Skornicki may publish in the future.

Co-authorship network of co-authors of Michelle Skornicki

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Skornicki. A scholar is included among the top collaborators of Michelle Skornicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Skornicki. Michelle Skornicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beck, Ekkehard, Elisha Beebe, Daina B. Esposito, et al.. (2024). Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States. Infectious Diseases and Therapy. 14(1). 199–216. 5 indexed citations
2.
Skornicki, Michelle, et al.. (2023). Healthcare resource utilization, costs and treatment associated with myasthenia gravis exacerbations among patients with myasthenia gravis in the USA: a retrospective analysis of claims data. Journal of Comparative Effectiveness Research. 13(1). e230108–e230108. 4 indexed citations
3.
Skornicki, Michelle, et al.. (2021). Clinical Burden of Concomitant Joint Disease in Psoriasis: A US-Linked Claims and Electronic Health Records Database Analysis. Advances in Therapy. 38(5). 2458–2471. 8 indexed citations
4.
5.
Sabolinski, Michael L., et al.. (2017). The Comparative Effectiveness of a Human Fibroblast Dermal Substitute versus a Dehydrated Human Amnion/Chorion Membrane Allograft for the Treatment of Diabetic Foot Ulcers in a Real-world Setting.. PubMed. 29(5). 125–132. 6 indexed citations
6.
Treadwell, Terry, Michael L. Sabolinski, Michelle Skornicki, & Nathan B. Parsons. (2017). Comparative Effectiveness of a Bioengineered Living Cellular Construct and Cryopreserved Cadaveric Skin Allograft for the Treatment of Venous Leg Ulcers in a Real-World Setting. Advances in Wound Care. 7(3). 69–76. 6 indexed citations
7.
Shafrin, Jason, et al.. (2016). Use of Net Monetary Benefit Analysis to Comprehensively Understand the Value of Innovative Treatments. Value in Health. 19(7). A731–A731. 9 indexed citations
8.
Rice, J. Bradford, et al.. (2015). Economic outcomes among medicare patients receiving skin substitutes for treatment of Diabetic foot Ulcers. Value in Health. 18(3). A43–A43. 1 indexed citations
9.
Rice, J. Bradford, Urvi Desai, Alice Kate G. Cummings, et al.. (2015). Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers. Journal of Medical Economics. 18(8). 586–595. 21 indexed citations
10.
McGarry, Lisa J., Girishanthy Krishnarajah, Cristina Masseria, et al.. (2014). Cost-Effectiveness of Tdap Vaccination of Adults Aged ≥65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission. PLoS ONE. 9(1). e72723–e72723. 24 indexed citations
11.
Skornicki, Michelle, Karen M. Clements, & Amy K. O’Sullivan. (2014). Budget Impact Analysis of Antiepileptic Drugs for Lennox-Gastaut Syndrome. Journal of Managed Care Pharmacy. 20(4). 400–406. 10 indexed citations
12.
Rice, J. Bradford, Urvi Desai, Alice Kate G. Cummings, et al.. (2014). Burden of venous leg ulcers in the United States. Journal of Medical Economics. 17(5). 347–356. 169 indexed citations
13.
Rice, J. Bradford, Urvi Desai, Alice Kate G. Cummings, et al.. (2013). Burden of Diabetic Foot Ulcers for Medicare and Private Insurers. Diabetes Care. 37(3). 651–658. 437 indexed citations breakdown →
14.
Rice, J. Bradford, Urvi Desai, Alice Kate G. Cummings, et al.. (2013). Medical, Drug, And Work-Loss Costs Of Diabetic Foot Ulcers. Value in Health. 16(3). A12–A12. 3 indexed citations
15.
Rice, J. Bradford, Urvi Desai, Alice Kate G. Cummings, et al.. (2013). Medical, Drug, And Work-Loss Costs Of Venous Leg Ulcers. Value in Health. 16(3). A73–A73. 4 indexed citations
16.
17.
McGarry, Lisa J., Girishanthy Krishnarajah, Michelle Skornicki, et al.. (2013). Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly. PLoS ONE. 8(9). e67260–e67260. 17 indexed citations
18.
McGarry, Lisa J., Girishanthy Krishnarajah, Cristina Masseria, et al.. (2012). Cost-effectiveness analysis of BOOSTRIX® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) among Individuals≥ 65 years of age in prevention of Pertussis. 201201. 2 indexed citations
19.
Skornicki, Michelle, et al.. (2012). PND6 Budget Impact Analysis of Antiepileptic Drugs in the Treatment of Lennox-Gastaut Syndrome. Value in Health. 15(4). A141–A142. 1 indexed citations
20.
Clements, Karen M., et al.. (2012). PND21 Cost-Effectiveness Analysis of Antiepileptic Drugs in the Treatment of Lennox-Gastaut Syndrome. Value in Health. 15(4). A144–A144. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Debure Breakdown of academic impact, for papers by John S. Steinberg Breakdown of academic impact, for papers by Sidnei Lastória Breakdown of academic impact, for papers by Lauren R. Bayer Breakdown of academic impact, for papers by Olle Nelzén Breakdown of academic impact, for papers by Cornelis G. Vos Breakdown of academic impact, for papers by Martin C. Robson Breakdown of academic impact, for papers by Satyendra K. Tiwary Breakdown of academic impact, for papers by Arife Polat Düzgün Breakdown of academic impact, for papers by Peter Davison
Rankless by CCL
2026